Reference health
Peptide and Protein Alphavirus Antigens for Broad Spectrum Vaccine Design
61/61 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
17 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 61 checked references that resolve
resolves10.4269/ajtmh.1999.61.579
Genetic and antigenic diversity among eastern equine encephalitis viruses from North, Central, and South America.
resolves10.1371/journal.pntd.0005693
Evolution and spread of Venezuelan equine encephalitis complex alphavirus in the Americas
resolves10.4269/ajtmh.1999.60.630
Geographic distribution of Venezuelan equine encephalitis virus subtype IE genotypes in Central America and Mexico.
resolves10.4269/ajtmh.1999.60.441
Genetic evidence for the origins of Venezuelan equine encephalitis virus subtype IAB outbreaks.
resolves10.1016/j.chom.2015.06.009
Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus
resolves10.1038/s41598-020-78009-7
Infectious RNA vaccine protects mice against chikungunya virus infection
resolves10.1128/JVI.00775-19
Chikungunya Virus Vaccine Candidates with Decreased Mutational Robustness Are Attenuated<i>In Vivo</i>and Have Compromised Transmissibility
resolves10.1016/j.vaccine.2018.10.033
Defining a correlate of protection for chikungunya virus vaccines
resolves10.1016/j.vaccine.2011.01.108
A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis
resolves10.1016/j.vaccine.2013.05.059
Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model
resolves10.1016/j.vaccine.2012.04.099
Cross-protective immunity against o‘nyong-nyong virus afforded by a novel recombinant chikungunya vaccine
resolves10.1016/S0140-6736(14)61185-5
Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial
resolves10.1016/j.vaccine.2018.05.095
A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections
resolves10.1016/j.vaccine.2012.07.072
Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus
resolves10.1371/journal.pntd.0007316
Vaccination with a chikungunya virus-like particle vaccine exacerbates disease in aged mice
resolves10.1016/j.virusres.2012.05.004
Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in mice
resolves10.1371/journal.ppat.1007584
Rational design of a live-attenuated eastern equine encephalitis virus vaccine through informed mutation of virulence determinants
resolves10.1016/j.omtm.2020.04.009
Nanoplasmid Vectors Co-expressing Innate Immune Agonists Enhance DNA Vaccines for Venezuelan Equine Encephalitis Virus and Ebola Virus
resolves10.1016/j.vaccine.2009.02.090
Immune interference after sequential alphavirus vaccine vaccinations
resolves10.1016/j.vaccine.2012.09.049
Immune interference in the setting of same-day administration of two similar inactivated alphavirus vaccines: Eastern equine and western equine encephalitis
resolves10.1016/j.jmb.2009.11.070
PCP Consensus Sequences of Flaviviruses: Correlating Variance with Vector Competence and Disease Phenotype
resolves10.1504/IJBRA.2010.032117
Flavitrack analysis of the structure and function of West Nile non-structural proteins
resolves10.3201/eid2710.211538
Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19
resolves10.4269/ajtmh.14-0055
Current Strategic Thinking for the Development of a Trivalent Alphavirus Vaccine for Human Use
resolves10.1016/j.antiviral.2012.04.002
Alphaviruses: Population genetics and determinants of emergence
resolves10.1016/j.virol.2020.11.010
Designing multivalent immunogens for alphavirus vaccine optimization
resolves10.1016/j.cell.2021.07.033
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress
resolves10.1073/pnas.2008051117
Structural basis of Chikungunya virus inhibition by monoclonal antibodies
resolves10.1016/j.chom.2020.07.008
Human mAbs Broadly Protect against Arthritogenic Alphaviruses by Recognizing Conserved Elements of the Mxra8 Receptor-Binding Site
resolves10.1016/j.antiviral.2020.104905
Producing physicochemical property consensus alphavirus protein antigens for broad spectrum vaccine design
resolves10.3201/eid2510.181610
Localized Outbreaks of Epidemic Polyarthritis among Military Personnel Caused by Different Sublineages of Ross River Virus, Northeastern Australia, 2016–2017
resolves10.1002/prot.22281
Mechanical stability and differentially conserved physical–chemical properties of titin Ig‐domains
resolves10.1074/jbc.M708582200
Identification and Analysis of Conserved Sequence Motifs in Cytochrome P450 Family 2
resolves10.1007/s00894-001-0058-5
New quantitative descriptors of amino acids based on multidimensional scaling of a large number of physical?chemical properties
resolves10.1016/j.vaccine.2012.07.042
Simplifying complex sequence information: A PCP-consensus protein binds antibodies against all four Dengue serotypes
resolves10.1016/j.virol.2015.05.016
Sequence specificity for uridylylation of the viral peptide linked to the genome (VPg) of enteroviruses
resolves10.1016/j.vaccine.2008.03.060
Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus
resolves10.1128/JVI.03152-15
Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses
resolves10.1016/j.vaccine.2011.01.100
A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets
resolves10.1038/nature09555
Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography
resolves10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W
Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules
resolves10.1016/0003-2697(87)90135-7
Variable selection method improves the prediction of protein secondary structure from circular dichroism spectra
resolves10.1002/prot.20676
The Protein Circular Dichroism Data Bank (PCDDB): A bioinformatics and spectroscopic resource
resolves10.1016/j.virol.2012.11.013
IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice
resolves10.1128/JVI.06449-11
Attenuation of Chikungunya Virus Vaccine Strain 181/Clone 25 Is Determined by Two Amino Acid Substitutions in the E2 Envelope Glycoprotein
resolves10.4269/ajtmh.1964.13.723
The Venezuelan Equine Encephalomyelitis Complex of Group a Arthropod-Borne Viruses, Including Mucambo and Pixuna from the Amazon Region of Brazil
resolves10.1128/JVI.02364-15
Structural Studies of Chikungunya Virus-Like Particles Complexed with Human Antibodies: Neutralization and Cell-to-Cell Transmission
resolves10.1128/JVI.01943-14
Exposure of Epitope Residues on the Outer Face of the Chikungunya Virus Envelope Trimer Determines Antibody Neutralizing Efficacy
resolves10.1371/journal.pntd.0003684
A Small Antigenic Determinant of the Chikungunya Virus E2 Protein Is Sufficient to Induce Neutralizing Antibodies which Are Partially Protective in Mice
resolves10.1038/s41579-020-00482-8
Population bottlenecks and founder effects: implications for mosquito-borne arboviral emergence
resolves10.3390/v6103991
Arboviral Bottlenecks and Challenges to Maintaining Diversity and Fitness during Mosquito Transmission
resolves10.1016/j.virol.2011.03.030
Differential accumulation of genetic and phenotypic changes in Venezuelan equine encephalitis virus and Japanese encephalitis virus following passage in vitro and in vivo
resolves10.1128/JVI.01286-14
Locking and Blocking the Viral Landscape of an Alphavirus with Neutralizing Antibodies
resolves10.1128/JVI.01495-20
High-Resolution Mapping of Human Norovirus Antigens via Genomic Phage Display Library Selections and Deep Sequencing
resolves10.1016/j.molimm.2020.03.017
Epitopes with similar physicochemical properties contribute to cross reactivity between peanut and tree nuts
The 17 references without a DOI — listed, not checked
no DOI — not checkedref6
no DOI — not checkedref7
no DOI — not checkedref8
no DOI — not checkedref10
no DOI — not checkedPlasmid DNA-based Alphavirus Vaccines
no DOI — not checkedVaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses
no DOI — not checkedSafety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, doseescalation
no DOI — not checkedRegional and temporal coordinated mutation patterns in SARS-CoV-2 spike protein revealed by a clustering and network analysis
no DOI — not checkedPan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope
no DOI — not checkedref42
no DOI — not checkedProtective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein
no DOI — not checkedref44
no DOI — not checkedref52
no DOI — not checkedref57
no DOI — not checkedref61
no DOI — not checkedref67
no DOI — not checkedref76
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2139/ssrn.4118572"><img src="https://citestamp.com/citestamped/10.2139/ssrn.4118572/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2139/ssrn.4118572)